The feasibility of obtaining oncotype DX breast recurrence score® results from metastatic sites of patients with hormone receptor positive metastatic breast cancer

被引：0
|
作者：
Gemmill, Julie Anne L. [1 ]
Thompson, Patricia [1 ]
Batiste, Rebecca [1 ]
Vacchi-Suzzi, Caterina [1 ]
Preece, Christina [1 ]
Cohen, Jules [1 ]
Baer, Lea [1 ]
Mies, Carolyn [2 ]
Turner, Michelle [2 ]
Russell, Christy A. [2 ]
Stopeck, Alison [1 ]
机构：
[1] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[2] Genom Hlth Inc, Redwood City, CA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS5-37
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of the Intermediate Oncotype DX Recurrence Score results on adjuvant treatment recommendations in hormone receptor-positive early breast cancer in a single center.
    De San Vicente, Borja Lopez
    Novas, Patricia
    Galve Calvo, Elena
    Fernandez, Sara
    Arrazubi, Virginia
    Angeles Sala, Maria
    Fernandez, Seila
    Arevalo, Alberto
    Fernando Arango, Juan
    Zumarraga, Ane
    Sande, Laura
    Teresa Perez-Hoyos, Maria
    Abad, Teresa
    Martinez del Prado, Purificacion
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Clinical outcomes and Oncotype DX Breast Recurrence Score (R) in early-stage BRCA-associated hormone receptor-positive breast cancer
    Layman, Rachel M.
    Lin, Heather
    Barrera, Angelica M. Gutierrez
    Karuturi, Meghan S.
    Yam, Clinton
    Arun, Banu K.
    CANCER MEDICINE, 2022, 11 (06): : 1474 - 1483
  • [23] Association of exogenous hormone use with breast cancer subtype defined by Oncotype DX recurrence score
    Benefield, Halei
    Reeder-Hayes, Katherine
    Wheeler, Stephanie
    Carey, Lisa
    Olshan, Andrew
    Troester, Melissa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 387 - 387
  • [24] Evaluation of the Oncotype Dx recurrence score (RS) in hormone-positive ipsilateral breast tumor recurrences
    Wapnir, Irene
    Florero, Marilyn
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Assessment of method of breast cancer detection and Oncotype DX recurrence score
    Kelly, Ciara Marie
    Parker, Imelda
    McCaffrey, John
    Crown, John
    O'Connor, Miriam
    McGee, Sharon F.
    Pusztai, Lajos
    Kelly, Catherine M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Impact of Oncotype DX Recurrence Score in the Management of Breast Cancer Cases
    Nguyen, Michaela T.
    Stessin, Alexander
    Nagar, Himanshu
    D'Alfonso, Timothy M.
    Chen, Zhengming
    Cigler, Tessa
    Hayes, Mary Kay
    Shin, Sandra J.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 182 - 190
  • [27] Correlation of Oncotype Dx Recurrence Score and Luminal Subtypes of Breast Cancer
    Henderson, S.
    Xie, X-J
    Peng, Y.
    Euhus, D.
    Leitch, M.
    Rao, R.
    Haley, B.
    Sarode, V.
    CANCER RESEARCH, 2010, 70
  • [28] Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
    Caitlin Taylor
    Jane Meisel
    Aimee J. Foreman
    Christy Russell
    Dipankar Bandyopadhyay
    Xiaoyan Deng
    Lisa Floyd
    Amelia Zelnak
    Harry Bear
    Ruth O’Regan
    Breast Cancer Research and Treatment, 2023, 199 : 91 - 98
  • [29] Oncotype DX score in hormone receptor-positive/HER2-positive breast cancer: A SEER analysis.
    Qasrawi, Ayman
    Myint, Zin
    Alnimer, Yanal Mufeed
    Romond, Edward H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
    Taylor, Caitlin
    Meisel, Jane
    Foreman, Aimee J.
    Russell, Christy
    Bandyopadhyay, Dipankar
    Deng, Xiaoyan
    Floyd, Lisa
    Zelnak, Amelia
    Bear, Harry
    O'Regan, Ruth
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (01) : 91 - 98
12345